Gildea Edward J 4

What Happened
Edward J. Gildea, a director of Marimed Inc. (MRMD), received an award of 75,000 restricted stock units (RSUs) on June 4, 2026. The award is recorded at $0.00 per unit (no cash paid on grant) and is a derivative equity grant rather than an immediate share purchase. These RSUs are described as the issuer’s annual non-employee director equity grant.

Key Details

• Transaction date: 2026-06-04; filed on Form 4: 2026-06-08 (filed within the two-business-day reporting window).
• Grant: 75,000 RSUs, grant price $0.00 (reported as an award/derivative).
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: F1 — RSUs convert to common stock one-for-one; F2 — RSUs vest in full one year from the grant date per the award agreement.
• Remark: RSUs represent the annual equity grant under the company’s non-employee director compensation program.

Context
RSUs are a form of compensation, not an immediate purchase or sale. These units will convert to common shares only upon vesting (one year after grant); there was no cash exchanged at grant and no immediate change in outstanding common shares held by the director. Such awards are routine for non-employee directors and reflect standard compensation practices rather than an open-market trading signal.